Latest News
In the world of e-commerce, Amazon isn't the only business generating serious returns for its shareholders.
Via The Motley Fool · October 12, 2025
Palantir's stock looks overdue for a correction, and these two rising AI stocks could end up overtaking it in value next year.
Via The Motley Fool · October 12, 2025
Effective September 30th, some 105000 Federal workers who had signed up for the Deferred Resignation Program were officially unemployed. So on top of even mild increases, numbers will look meaningfully
Via Talk Markets · October 12, 2025
Trump admin admits immigration policies could disrupt US agriculture, drive food shortages and higher prices.
Via Benzinga · October 12, 2025
Via Talk Markets · October 12, 2025
Here are the scheduled economic data releases for the next two weeks, if the agencies have staff to release data.
Via Talk Markets · October 12, 2025
One of the hardest things for stock and options traders is finding the sell button.
Via Talk Markets · October 12, 2025
A Social Security dollar simply isn't what it used to be.
Via The Motley Fool · October 12, 2025
A seldom-observed event on Wall Street portends trouble for stocks.
Via The Motley Fool · October 12, 2025
Lock in high returns before banks lower rates. High-yield savings accounts surge to 5% APY amid Fed's interest rate cuts.
Via Benzinga · October 12, 2025
We discuss gold's historic surge past $4,000, the dollar's decline, and warn of looming economic crises and fiscal irresponsibility.
Via Talk Markets · October 12, 2025
Zohran Mamdani calls Trump's indictment of Letitia James political retaliation, highlighting a pattern of targeting opponents.
Via Benzinga · October 12, 2025
Europe wants fairness. But fairness for whom?
Via Talk Markets · October 11, 2025
And is an exchange default imminent? The structural silver deficit is international.
Via Talk Markets · October 11, 2025
AI and humans must work together for success in the future job market. The CIO of Goldman Sachs offers tips for managing hybrid teams.
Via Benzinga · October 12, 2025
During the shutdown, Sean Duffy warned controllers who call in sick instead of working without pay could be fired.
Via Benzinga · October 12, 2025
Schiff stands against Trump's legal threats, vows to continue fighting back. High-profile indictments raise fears of political retaliation.
Via Benzinga · October 12, 2025
Via The Motley Fool · October 11, 2025
Federal appeals court grants interim stay, barring National Guard deployed by Trump in Illinois from protecting federal property.
Via Benzinga · October 11, 2025
Today's math lesson.
Via Talk Markets · October 11, 2025
Industrial supplier Fastenal (NASDAQ:FAST) will be reporting results this Monday morning. Here’s what investors should know.
Via StockStory · October 11, 2025
Trump's 100% China tariff triggered $16 billion in crypto liquidations and sent Bitcoin below $110,000 in historic sell-off.
Via Talk Markets · October 11, 2025
Trump orders Pentagon to use existing funds to pay military during shutdown, excludes Coast Guard. Republicans, Democrats clash over shutdown
Via Benzinga · October 11, 2025
Via The Motley Fool · October 11, 2025
Via Benzinga · October 11, 2025
Via Benzinga · October 11, 2025
The October report shows that consumers remain pessimistic as the overall Index of Consumer Sentiment ticked down to 55.0 from 55.1 in September.
Via Talk Markets · October 11, 2025
Via The Motley Fool · October 11, 2025
Via Benzinga · October 11, 2025
The market provided a little drama last Friday; something to stew about over the weekend. Volume was impressive, could have been a record. It was too soon after all time highs to be the beginning of a bear market.
Via Talk Markets · October 11, 2025
This stock constantly trades at a premium valuation and leaves competitors in the dust with margins, but stumbled Thursday -- is it a buying opportunity?
Via The Motley Fool · October 11, 2025
DraftKings and e.l.f. are attractively valued stocks growing quickly.
Via The Motley Fool · October 11, 2025
Amazon's stock has lost its luster lately, but there are still plenty of opportunities for the company.
Via The Motley Fool · October 11, 2025
BigBear.ai was rejected at the $7.8 to $8.2 range this summer and declined all the way to $4.7 in September, before rising again to $8 and being rejected again.
Via Talk Markets · October 11, 2025
Building wealth isn't just about dividends -- it is about consistently growing a business through good times and bad.
Via The Motley Fool · October 11, 2025
Energy Transfer is a great stock to buy when it's down.
Via The Motley Fool · October 11, 2025
Target is a Dividend King by virtue of its 54 consecutive annual dividend increases.
Via The Motley Fool · October 11, 2025
Rocket Lab has been a big winner for investors this year.
Via The Motley Fool · October 11, 2025
This semiconductor and networking specialist is a rising force in the artificial intelligence (AI) space.
Via The Motley Fool · October 11, 2025
Making predictions on Wall Street is usually a mistake, but I'm confident about one call when it comes to high-yield Ares Capital.
Via The Motley Fool · October 11, 2025
The dollar saw its weekly gains pared but it still settled higher against all the G10 currencies.
Via Talk Markets · October 11, 2025
Via The Motley Fool · October 11, 2025
The broadcast radio and television industry has been benefiting from a massive spike in digital content consumption. Companies in the space are thriving due to their diverse content offerings. Thus, here are stocks that may be worth consideration.
Via Talk Markets · October 11, 2025
President Donald Trump announced plans for tariff of 100% on Chinese imports starting Nov. 1, causing major technology stocks to lose approximately $770 billion in value on Friday. The Nasdaq dropped 3.6% while the S&P 500 fell 2.7%.
Via Talk Markets · October 11, 2025
In this video, I explore the recent downturn in the stock market and explain why the S&P 500 dropped so swiftly in Friday's trading.
Via Talk Markets · October 11, 2025
Via Benzinga · October 11, 2025
Esperion Therapeutics Inc. and Otsuka recently announced regulatory approval for NEXLETOL in Japan. Pending pricing, which Esperion estimates will take roughly one to two months, the company should receive a $120 million milestone from Otsuka.
Via Talk Markets · October 11, 2025